Effect of Risedronate Sodium on Nausea and Vomiting Caused by Heavy Exercise

Effect of Risedronate Sodium on Nausea and Vomiting Caused by Heavy Exercise - Effect of Risedronate Sodium on Nausea and Vomiting Caused by Heavy Exercise

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000032110

Enrollment

100

Registered

2018-04-05

Start date

2018-03-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

none

Interventions

Pre-exercise oral medication of Risedronate sodium (3 &amp

10 days before exercise) Pre-exercise oral medication of Placebo (3 &amp

10 days before exercise)

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Japan Self-Defense Force Members in the Airborne Ranger Training Course

Exclusion criteria

Exclusion criteria: - Members contraindicated for Risedronate sodium - Members who are considered inappropriate for this trial by the principal investigator

Design outcomes

Primary

Measure	Time frame
The degree of nausea and vomiting during- or post-exercise	—

Secondary

Measure	Time frame
- Post-exercise blood calcium, serum TRACP-5b levels, and eGFR - The degree of clinical symptoms of heatstroke	—

Countries

Japan

Contacts

Public ContactKenji Okuyama

Self-Defense Forces Central Hospital Department of research

research4-c-hosp@inet.gsdf.mod.go.jp03-3411-0151

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026